Literature DB >> 11911824

FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection.

A Ioan-Facsinay1, S J de Kimpe, S M M Hellwig, P L van Lent, F M A Hofhuis, H H van Ojik, C Sedlik, S A da Silveira, J Gerber, Y F de Jong, R Roozendaal, L A Aarden, W B van den Berg, T Saito, D Mosser, S Amigorena, S Izui, G J B van Ommen, M van Vugt, J G J van de Winkel, J S Verbeek.   

Abstract

The high-affinity receptor for IgG, FcgammaRI, shares its capacity to bind IgG2a immune complexes (IgG2a-IC) with the low-affinity receptor FcgammaRIII and complement factors, hampering the definition of its biological role. Moreover, in vivo, FcgammaRI is occupied by monomeric IgG2a, reducing its accessibility to newly formed IgG2a-IC. By using a variety of FcgammaR(-/-) mice, we demonstrate that in the absence of FcgammaRI, the IgG2a-IC-induced cellular processes of phagocytosis, cytokine release, cellular cytotoxicity, and antigen presentation are impaired. FcgammaRI(-/-) mice showed impaired hypersensitivity responses, strongly reduced cartilage destruction in an arthritis model, and impaired protection from a bacterial infection. We conclude that FcgammaRI contributes substantially to a variety of IgG2a-IC-dependent immune functions and immunopathological responses.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11911824     DOI: 10.1016/s1074-7613(02)00294-7

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  103 in total

1.  Humoral immunity against Bordetella pertussis: antibodies or B cells?

Authors:  María Eugenia Rodriguez; W-Ludo van der Pol
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

2.  MicroRNA-127 inhibits lung inflammation by targeting IgG Fcγ receptor I.

Authors:  Ting Xie; Jiurong Liang; Ningshan Liu; Qingguo Wang; Yuhang Li; Paul W Noble; Dianhua Jiang
Journal:  J Immunol       Date:  2012-01-27       Impact factor: 5.422

Review 3.  Activating and inhibitory FcgammaRs in autoimmune disorders.

Authors:  Falk Nimmerjahn
Journal:  Springer Semin Immunopathol       Date:  2006-10-01

4.  IgG1 is pathogenic in Leishmania mexicana infection.

Authors:  Niansheng Chu; Bolaji N Thomas; Supriya R Patel; Laurence U Buxbaum
Journal:  J Immunol       Date:  2010-10-29       Impact factor: 5.422

5.  Immune complexes as therapy for autoimmunity.

Authors:  Raphael Clynes
Journal:  J Clin Invest       Date:  2005-01       Impact factor: 14.808

6.  FcγRIV deletion reveals its central role for IgG2a and IgG2b activity in vivo.

Authors:  Falk Nimmerjahn; Anja Lux; Heike Albert; Melissa Woigk; Christian Lehmann; Diana Dudziak; Patrick Smith; Jeffrey V Ravetch
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

7.  Fc gamma RIII and Fc gamma RIV are indispensable for acute glomerular inflammation induced by switch variant monoclonal antibodies.

Authors:  Angela Giorgini; Heather J Brown; Helen R Lock; Falk Nimmerjahn; Jeffrey V Ravetch; J Sjef Verbeek; Steven H Sacks; Michael G Robson
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

8.  Regulation of FcRγ function by site-specific serine phosphorylation.

Authors:  Spandan Shah; Andrew W Gibson; Chuanyi Ji; Eric Darrington; James Mobley; Kyoko Kojima; Jeffrey C Edberg; Robert P Kimberly
Journal:  J Leukoc Biol       Date:  2016-09-14       Impact factor: 4.962

Review 9.  Fc receptors and their role in immune regulation and autoimmunity.

Authors:  Toshiyuki Takai
Journal:  J Clin Immunol       Date:  2005-01       Impact factor: 8.317

10.  Macrophages eliminate circulating tumor cells after monoclonal antibody therapy.

Authors:  Nuray Gül; Liane Babes; Kerstin Siegmund; Rianne Korthouwer; Marijn Bögels; Rens Braster; Gestur Vidarsson; Timo L M ten Hagen; Paul Kubes; Marjolein van Egmond
Journal:  J Clin Invest       Date:  2014-01-16       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.